Form 4: Orthopediatrics Corp. Director Harold Ruf Trades Shares

Orthopediatrics Corp. Director Harold Ruf reported a transaction involving common stock on June 9, 2026.

Summary

• Director Harold Ruf of Orthopediatrics Corp. (KIDS) acquired 11,436 shares of common stock on June 9, 2026, for $0.
• Following this transaction, Ruf beneficially owns 19,837 shares directly.
• Additionally, Ruf has indirect beneficial ownership of 19,247 shares held by The Last Chance Legacy Trust and 2,400 shares held by the Harald Ruf Roth IRA.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it reports a routine insider stock transaction without providing new financial performance or strategic information.

Positives

• Director Harold Ruf acquired 11,436 shares of common stock, indicating continued investment or alignment with the company.
• The acquisition was made at a price of $0, suggesting these may be performance-based awards or part of a compensation package.

Future Outlook

No specific future outlook or guidance is provided in this Form 4 filing, which primarily reports on past transactions.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not typically offer strategic insights. The focus here is on the reporting person's direct and indirect beneficial ownership of Orthopediatrics Corp. (KIDS) stock.

Stakeholder Impact

• Shareholders: The transaction provides transparency regarding director holdings, which can inform investor perception of insider confidence.

Key Dates

Keywords

Orthopediatrics Corp, KIDS, Form 4, SEC Filing, Director, Stock Transaction, Beneficial Ownership, Common Stock